LumiraDx comes up with a point of care diagnostic tool to screen the C-Reactive Protein in the blood from a single drop, which helps to prescribe specific antibiotics. This newly launched device is handy and to be available in various labs across India.
LumiraDx Healthcare Pvt Ltd are the pioneers in developing, manufacturing and commercializing Point Of Care (POC) Diagnostic tools. They plug into the cloud based technology to manage the data across the healthcare system. On Thursday, they inaugurated their new front runner C-Reactive protein, an antigen test across India.
Need For an CRP Antigen Test
In the World Antimicrobial Awareness week (WAAW), the alarming increase in antimicrobial resistance in people around the globe came into the spotlight. Administration of broad spectrum antibiotics for any infection or illness has exposed the body to a wide range of antibiotics which has led to developing resistance against antimicrobial drugs. Thus, a highly precise and sensitive diagnostic tool is a boon to screen the pathogen and treat accordingly.
How does the LumiraDX CRP test works
The C-Reactive Protein is an antigen test, which scans the CRP levels in the blood. CRP is a protein molecule produced by the liver. When a person is affected by an infection, underlying disease or an injury his CRP level is said to be high indicating inflammation caused due to the infection. The normal range of CRP levels in an individual is 3.0 mg/L. The tool by LumiraDx weighing less than a kg comes in handy and gives instant results on your CRP levels.
All Set to Fight Antimicrobial Resistance
Drug development on new antimicrobials is almost zero to nil. Thus, reducing the antimicrobial resistance is essential to combat against the global concern on drug refusing pathogens. The Point of care diagnosis of CPR protein reduces dictating antibiotics in 22% of COPD cases and of 23-36 % respiratory tract illness and infections. In this method to a certain degree the antimicrobial resistance (AMR) threat can be managed.
Yogesh Singh, General Manager, and Dr Nigel Lindner, Chief Innovation Officer of LumiraDx states that they support WAAW and the doctors with the advent of their new product – CRP protein test launch, which aids the healthcare system to put up a shield in a sustainable way against the growing antimicrobial resistance.
The Indian government has put out AMR stewardship programmes throughout the nation to control the AMR health crisis. Hospitals, Primary healthcare centers, Pediatric clinics, General practitioners, Intensive care units, and Out-patient departments are sternly advised to set up the CRP test for a quick analysis to beat the AMR demon.
READ MORE:Singapore to sell cultured seafood to the world #1
